Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections

Background: In recent years there has been an increase in the use of erythromycin in the treatment of infections caused by bacteria other than Group A Streptococcus (GAS), which has resulted in increased resistance to this antibiotic. Erythromycin and other macrolides are alternative agents for...

Full description

Bibliographic Details
Main Authors: Sunil Shivekar, Thangam Menon
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-11-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/6843/14744_CE(RA1)_F(T)_PF1(PAK)_PFA(AK)_PF2(PAG).pdf
_version_ 1819225066349527040
author Sunil Shivekar
Thangam Menon
author_facet Sunil Shivekar
Thangam Menon
author_sort Sunil Shivekar
collection DOAJ
description Background: In recent years there has been an increase in the use of erythromycin in the treatment of infections caused by bacteria other than Group A Streptococcus (GAS), which has resulted in increased resistance to this antibiotic. Erythromycin and other macrolides are alternative agents for treating GAS infections in patients, who are allergic to penicillin and its derivatives. Aim: The main aim of this study was to identify frequency, pattern and genetic determinant of erythromycin resistance among the GAS isolated from skin and soft tissue infections. Materials and Methods: A total 100 isolates of GAS were screened for erythromycin resistance by phenotypic and genotypic method. Results: The results of the present study showed that 38% isolates were resistant to erythromycin. The iMLS (inducible macrolide-lincosamide-streptogramin) phenotype was predominant (55.26%) followed by M phenotype (26.32%) and cMLS (constitutive macrolide-lincosamide-streptogramin) (18.42%). Conclusion: Phenotypic and genotypic analysis showed that the MLSB phenotype with ermB mediated mechanism of resistance was found the most common (76.31%) followed by mefA (20.51%). The ermTR genes was absent in all the isolates.
first_indexed 2024-12-23T10:03:41Z
format Article
id doaj.art-0d6d4e7394934a09a8a73737c69a2b79
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-23T10:03:41Z
publishDate 2015-11-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-0d6d4e7394934a09a8a73737c69a2b792022-12-21T17:51:08ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2015-11-01911DC21DC2310.7860/JCDR/2015/14744.6843Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue InfectionsSunil Shivekar0Thangam Menon1PhD Scholar, Department of Microbiology, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai, India.Director and HOD, Department of Microbiology, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai, India.Background: In recent years there has been an increase in the use of erythromycin in the treatment of infections caused by bacteria other than Group A Streptococcus (GAS), which has resulted in increased resistance to this antibiotic. Erythromycin and other macrolides are alternative agents for treating GAS infections in patients, who are allergic to penicillin and its derivatives. Aim: The main aim of this study was to identify frequency, pattern and genetic determinant of erythromycin resistance among the GAS isolated from skin and soft tissue infections. Materials and Methods: A total 100 isolates of GAS were screened for erythromycin resistance by phenotypic and genotypic method. Results: The results of the present study showed that 38% isolates were resistant to erythromycin. The iMLS (inducible macrolide-lincosamide-streptogramin) phenotype was predominant (55.26%) followed by M phenotype (26.32%) and cMLS (constitutive macrolide-lincosamide-streptogramin) (18.42%). Conclusion: Phenotypic and genotypic analysis showed that the MLSB phenotype with ermB mediated mechanism of resistance was found the most common (76.31%) followed by mefA (20.51%). The ermTR genes was absent in all the isolates.https://jcdr.net/articles/PDF/6843/14744_CE(RA1)_F(T)_PF1(PAK)_PFA(AK)_PF2(PAG).pdferythromycin resistancegenotypesphenotypes
spellingShingle Sunil Shivekar
Thangam Menon
Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections
Journal of Clinical and Diagnostic Research
erythromycin resistance
genotypes
phenotypes
title Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections
title_full Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections
title_fullStr Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections
title_full_unstemmed Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections
title_short Molecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections
title_sort molecular basis for erythromycin resistance in group a streptococcus isolated from skin and soft tissue infections
topic erythromycin resistance
genotypes
phenotypes
url https://jcdr.net/articles/PDF/6843/14744_CE(RA1)_F(T)_PF1(PAK)_PFA(AK)_PF2(PAG).pdf
work_keys_str_mv AT sunilshivekar molecularbasisforerythromycinresistanceingroupastreptococcusisolatedfromskinandsofttissueinfections
AT thangammenon molecularbasisforerythromycinresistanceingroupastreptococcusisolatedfromskinandsofttissueinfections